Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding TrialJohn A. Todd, Frank Waldron-Lynch, Kevin W. Loudon et al.|PLoS Medicine|2016Cited by 140
ACE Inhibitors and Statins in Adolescents with Type 1 DiabetesM. Loredana Marcovecchio, David B. Dunger, Scott T. Chiesa et al.|New England Journal of Medicine|2017Cited by 111
Early phase clinical trials extension to guidelines for the content of statistical analysis plansVictoria Homer, Piers Gaunt, Christina Yap et al.|BMJ|2022Cited by 67
Quality of stepped-wedge trial reporting can be reliably assessed using an updated CONSORT: crowd-sourcing systematic reviewKarla Hemming, Caroline Kristunas, Kelly Carroll et al.|Journal of Clinical Epidemiology|2018Cited by 35
What Factors Determine Treatment Outcome in Aneurysmal Subarachnoid Hemorrhage in the Modern Era? A Post Hoc STASH AnalysisMario Teo, Laura Montague, Mathew R. Guilfoyle et al.|World Neurosurgery|2017Cited by 24